The American Cancer Society and American Cancer Society Cancer Action Network (ACS CAN) are committed to reducing cancer incidence and deaths nationwide.
The Centers for Medicare and Medicaid Services (CMS) announced this week that it will not proceed with additional flexibilities to a Part D Payment Modernization Model that would have allowed participating Medicare Part D plans to limit coverage of drugs within the “six protected drug classes.”
Today Congress finished its work passing legislation that will expand access to health care coverage to more Americans, including cancer patients and survivors, who may have lost their insurance due to the ongoing pandemic.
The bill now goes to the president to be signed into law.
The U.S. Senate has passed legislation that will expand access to health care coverage to more Americans, including cancer patients and survivors, who may have lost their insurance due to the ongoing pandemic.
The U.S. House of Representatives is likely to pass legislation today that would increase access to health coverage for millions of Americans, including cancer patients and survivors, as part of its pandemic relief package.
The Association for Clinical Oncology (ASCO) and ACS CAN today issued a joint letter to every governor in the United States urging them to prioritize patients with cancer in the distribution of COVID-19 vaccines in accordance with U.S. Centers for Disease Control and Prevention (CDC) guidelines.
The U.S. House of Representatives will soon consider legislation to increase access to health coverage for millions of Americans, including cancer patients and survivors, as part of its pandemic relief package.
Washington, D.C.—Today President Biden is expected to issue several executive orders aimed at expanding potential health coverage options for those who have lost health insurance due to the coronavirus pandemic, and rollback current policies that harm patient access to coverage.
Cancer patients would likely be among those most affected by a proposed rule tying certain Medicare Part B drug reimbursement rates to that of foreign countries.